Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

18.20
Delayed Data
As of Sep 22
 +0.69 / +3.94%
Today’s Change
6.11
Today|||52-Week Range
18.54
+150.69%
Year-to-Date

Today’s Trading

Previous close17.51
Today’s open17.41
Day’s range17.27 - 18.42
Volume1,582,183
Average volume (3 months)1,150,977
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+492.86%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+61.72%
P/E ratio91.0
Price/Sales9.87
Price/Book49.57

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.14-1.59%
TBPHTheravance Biopharma...-0.01-0.03%
CBMCambrex Corp+0.60+1.12%
AERIAerie Pharmaceutical...-0.50-0.97%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$81.3M
Annual profit (last year)$8.1M
Net profit margin10.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts